Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794963 · ClinicalTrials.gov registry record · NA
Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00794963: Clinical Trial NA study, sponsored by Northwell Health.
NCT00794963 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00794963, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Schizophrenia patients treated with clozapine have a high prevalence of obesity-related metabolic syndrome. The condition is often poorly treated and may lead to the emergence of coronary heart disease and type 2 diabetes. The study will investigate whether structured treatment provided at the site of the outpatient psychiatric clinic of metabolic syndrome in this population will decrease the severity of metabolic syndrome as compared with usual care received by these patients in the community.
Interventions
- DRUG Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan
- OTHER As selected by community physician
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-05 |
| Phase | NA |
Why NCT00794963 stopped before completion
NCT00794963 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan is the first listed.
NCT00794963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00794963 about?
NCT00794963 is a clinical study titled "Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia". Schizophrenia patients treated with clozapine have a high prevalence of obesity-related metabolic syndrome. The condition is often poorly treated and may lead to the emergence of coronary heart disease and type 2 diabetes. The study will investigate whether structured treatment provided at the site ...
What is the current status of trial NCT00794963?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00794963?
The interventions under investigation include: Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan (DRUG), As selected by community physician (OTHER).
Who is sponsoring clinical trial NCT00794963?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00794963's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia